Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Regimens for BPD Prevention in Preterm Infants
NCT07052201Phase 3Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in bronchopulmonary dysplasia (BPD), sponsored by Children's Hospital, Zhejiang University School of Medicine. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT07052201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07052201.